ABSTRACT
Objetivo Elaborar una relación de nombres de medicamentos similares con letras mayúsculas resaltadas, que facilite y estandarice la implantación de esta técnica en prácticas dirigidas a reducir errores por similitud de nombres. Material y métodos Se realizaron dos encuestas estructuradas. La primera incluyó 46 pares, grupos o nombres de medicamentos similares con letras mayúsculas, procedentes de las listas establecidas por la FDA, ISMP y CAPCA/ISMP-Canadá, y 32 seleccionados de la base de datos del ISMP-España y Consejo de COF. La segunda incluyó 27 pares, grupos o nombres propuestos por los encuestados y 11 procedentes de la actualización del ISMP. Se formularon preguntas sobre la utilidad de la técnica y su implantación en los hospitales. Participaron en la primera encuesta 90 farmacéuticos de diferentes hospitales y 89 en la segunda. Resultados La relación de nombres de medicamentos similares con letras mayúsculas resaltadas elaborada recoge 107 nombres agrupados en 44 pares o grupos. Un 93,3% de los encuestados opinó que esta técnica debería implantarse para denominar a los medicamentos, tanto en el etiquetado de la industria farmacéutica (91,1%) como en otros lugares donde aparecen los nombres, como en las pantallas de prescripción informatizada (90%), de farmacia (82,2%) o de los sistemas automatizados de dispensación (81,1%), en etiquetado de preparaciones y estantes, etc. Solo 9 (10%) de los hospitales utilizaban esta técnica. Conclusiones La disponibilidad de esta relación de nombres similares en los que se recomienda utilizar letras mayúsculas resaltadas podría facilitar su aplicación en prácticas de diferenciación de nombres, actualmente reducida en nuestro país(AU)
Objective To develop a list of look-alike drug names with tall man letters, that will facilitate and standardize the implementation of this technique in safety practices designed to reduce errors caused by look-alike names. Material and methods Two structured surveys were carried out. The first survey included 46 pairs, groups, or individual look-alike drug names with tall man letters from the lists established by the FDA, ISMP and CAPCA/ISMP-Canada, and 32 selected from ISMP-Spain and the COF Council database. The second survey included 27 proposals made by those respondents who completed the first survey and 11 from the ISMP updated list. Participants were asked about the usefulness and current implementation of the technique. Ninety pharmacists from different hospitals participated in the first survey and 89 in the second. Results The list of look-alike drug names with tall man letters which has been developed includes 107 names structured into 44 pairs or groups. Of the respondents, 93.3% felt that this technique should be implemented for identifying medications, not only on pharmaceutical industry labels (91.1%) but also in other places where drug names appear, including computerized prescription screens (90%), pharmacy system screens (82.2%), automated dispensing cabinet screens (81.1%), labels for pharmacy preparations and shelves, etc. Only 9 hospitals (10%) were using this technique. Conclusions The availability of this list of look-alike drug names for which tall man lettering is recommended may encourage the use of this technique for differentiating names in Spain where it is currently not greatly used (AU)
Subject(s)
Humans , Drug Labeling/standards , Medication Errors/prevention & control , Drug Prescriptions/standards , Safety Management/methods , Pharmacy Service, Hospital/standards , Similar DrugsABSTRACT
OBJECTIVE: To develop a list of look-alike drug names with tall man letters, which will facilitate and standardize the implementation of this technique in safety practices designed to reduce errors caused by look-alike names. MATERIAL AND METHODS: Two structured surveys were carried out. The first survey included 46 pairs, groups, or individual look-alike drug names with tall man letters from the lists established by the FDA, ISMP and CAPCA/ISMP-Canada, and 32 selected from ISMP-Spain and the COF Council database. The second survey included 27 proposals made by those respondents who completed the first survey and 11 from the ISMP updated list. Participants were asked about the usefulness and current implementation of the technique. Ninety pharmacists from different hospitals participated in the first survey and 89 in the second. RESULTS: The list of look-alike drug names with tall man letters which has been developed includes 107 names structured into 44 pairs or groups. Of the respondents, 93.3% felt that this technique should be implemented for identifying medications, not only on pharmaceutical industry labels (91.1%) but also in other places where drug names appear, such as computerized prescription screens (90%), pharmacy system screens (82.2%), automated dispensing cabinet screens (81.1%), labels for pharmacy preparations and shelves, etc. Only 9 hospitals (10%) were using this technique. CONCLUSIONS: The availability of this list of look-alike drug names for which tall man lettering is recommended may encourage the use of this technique for differentiating names in Spain where it is currently not greatly used.
Subject(s)
Drug Labeling/methods , Drug Labeling/standards , Medication Errors/prevention & control , HumansABSTRACT
OBJECTIVE: Intravesical instillation of bacillus Calmette-Guerin (BCG) is an established treatment of carcinoma in situ and recurrent superficial bladder tumours. The inflammatory reaction due to BCG provokes cystitis of short duration as a frequent side effect. When the symptomatology is severe and long-lasting, different systemic treatments have been administered with varying degrees of efficacy. MATERIAL AND METHODS: We have studied the treatment of severe BCG cystitis with a anaesthetic anti-inflammatory solution administered by intravesical instillations to 16 patients. RESULTS: Good results were obtained in 94% of the cases, with immediate clinical improvement in terms of pain and urinary symptoms, and with no side effects. CONCLUSIONS: This treatment is inexpensive and easy to administer. We consider that it offers a useful option to solve an infrequent but very annoying problem for the patients.